Financials
Income statement
| Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.2B | 5.4B | 3.7B | 3.7B |
| Cost of revenue | 1.8B | 3.5B | 2.1B | 2.1B |
| Gross profit | 1.4B | 1.9B | 1.6B | 1.6B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 1.2B | 1.5B | 1.3B | 1.3B |
| Other operating expenses | — | — | — | — |
| Operating income | 60M | 202M | 98M | 166M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 76M | 74M | 76M | 86M |
| Other income expense | — | — | — | — |
| Pretax income | -16M | 52M | 22M | 80M |
| Tax provision | -1M | 4M | 0 | 14M |
| Net income | -15M | 48M | 22M | 66M |
| Basic EPS | -0.1 | 0.4 | 0.2 | 0.6 |
| Diluted EPS | -0.1 | 0.4 | 0.2 | 0.6 |
| Basic average shares | 111M | 111M | 111M | 111M |
| Diluted average shares | 111M | 112M | 112M | 112M |
| EBITDA | 235M | 309M | 282M | 354M |
| Net income from continuing op. | -15M | 48M | 22M | 66M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |